Akebia Therapeutics, Inc.

Historical 13F Holders

Symbol
AKBA
CUSIP
00972D105
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 00972D105 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 7.2% 1/21/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
State Street Corp 13G 4.3% 5/12/2026
Event 3/31/2026
Satter Muneer A 13G/A 2.6% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 158 109 M $100M
2026 Q2 171 108 M $123M
2026 Q1 172 102 M $141M
2025 Q4 167 118 M $190M
2025 Q3 177 124 M $338M
2025 Q2 160 108 M $394M
2025 Q1 145 95.5 M $203M
2024 Q4 124 67.8 M $129M
2024 Q3 117 59.4 M $78.4M
2024 Q2 105 56.3 M $57.4M
2024 Q1 121 57.0 M $104M
2023 Q4 90 54.8 M $72.7M
2023 Q3 80 50.9 M $58.0M
2023 Q2 80 50.3 M $46.0M
2023 Q1 68 52.0 M $30.9M
2022 Q4 76 52.3 M $30.9M
2022 Q3 94 52.2 M $16.5M
2022 Q2 101 57.5 M $20.2M
2022 Q1 133 81.2 M $58.3M
2021 Q4 134 96.8 M $219M
2021 Q3 128 98.5 M $284M
2021 Q2 141 106 M $402M
2021 Q1 149 101 M $340M
2020 Q4 147 104 M $294M
2020 Q3 168 102 M $268M
2020 Q2 193 112 M $1.52B
2020 Q1 157 92.8 M $703M
2019 Q4 155 84.2 M $532M
2019 Q3 151 85.2 M $334M
2019 Q2 152 87.0 M $421M
2019 Q1 175 84.7 M $694M
2018 Q4 169 81.1 M $448M
2018 Q3 132 41.1 M $363M
2018 Q2 146 43.0 M $537M
2018 Q1 155 43.4 M $412M
2017 Q4 134 33.7 M $501M
2017 Q3 122 30.2 M $593M
2017 Q2 119 27.3 M $392M
2017 Q1 91 20.8 M $191M
2016 Q4 96 20.2 M $210M
2016 Q3 89 19.6 M $177M
2016 Q2 95 19.6 M $147M
2016 Q1 93 21.1 M $191M
2015 Q4 91 16.3 M $209M
2015 Q3 83 15.1 M $150M
2015 Q2 74 12.7 M $136M
2015 Q1 62 7.47 M $88.3M
2014 Q4 57 7.56 M $94.5M
2014 Q3 53 7.57 M $170M
2014 Q2 50 8.70 M $242M
2014 Q1 3 104 k $2.03M